Johnson & Johnson SA de CV, Prestige Consumer Healthcare Inc., CINFA LABORATORIES are Dominating the Mexico Dimenhydrinate Market in 2022

Mexico Dimenhydrinate Market is expected to grow with a CAGR of 2.4% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/mexico-dimenhydrinate-market

The Mexico dimenhydrinate market is a highly consolidated market. It has witnessed increased strategic developments owing to favorable market scenarios.

Major players dealing in the mexico dimenhydrinate market are introducing a wide range of products. This helped companies to maximize sales with an enhanced product portfolio.

  • In July 2021, Prestige Consumer Healthcare announced that it had completed the acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation

Some of the key players operating in this market are Johnson & Johnson SA de CV, Prestige Consumer Healthcare Inc., CINFA LABORATORIES (a subsidiary of Mundipharma), and others.

Mexico Dimenhydrinate MarketJohnson & Johnson SA de CV

Johnson & Johnson SA de CV was founded in 1888 and is headquartered in New Jersey, U.S. It has public ownership. The company focuses on improving access and affordability to create healthier communities and put a healthy mind, body, and environment within reach of everyone. It deals in various business segments, including Consumer Health, Medical Devices, and Pharmaceutical Products, out of which Consumer Health is the market-focused segment. It also offers a wide range of product categories, including baby care, vision care, health care, oral care, and skin care, out of which health care is the market-focused category. The company is taking strategic initiatives to increase its portfolio.

The company has a global presence in North America, Asia-Pacific, South America, and Europe. It operated through various subsidiaries, including Acclarent, Inc. (Delaware), Actelion Pharmaceuticals US, Inc. (Delaware), Akros Medical, Inc. (Delaware) Albany Street LLC (New Jersey), ALZA Corporation (Delaware), Alza Land Management, Inc. (Delaware), AMO Development, LLC (Delaware), AMO Manufacturing USA, LLC (Delaware), AMO Nominee Holdings, LLC Delaware, AMO Sales and Service, Inc. (Delaware), among others.

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in New York, U.S. It has private ownership. The company focuses on developing, manufacturing, sales, and distribution of over-the-counter healthcare and house cleaning products. The company offers product categories including over the counter products, household cleaning products, and personal care products, in which over the counter products fall under the market-focused category. The company is increasing its product portfolio through various developments.

For instance:

  • In July 2021, Prestige Consumer Healthcare announced that it had completed the acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation

The company has a global presence in North America. It operates through various subsidiaries, including Bonita Bay Holdings, Inc.(U.S.), Prestige Acquisition Holdings, LLC(U.S.), Prestige Brands Financial Corporation (U.S.), Prestige Brands Holdings, Inc.(U.S.), Prestige Brands, Inc. (U.S.), among others.

CINFA LABORATORIES (a subsidiary of Mundipharma)

CINFA LABORATORIES was founded in 1969 and is headquartered in Navarra, Spain. It has private ownership. The company focuses on making solutions available to patients that guarantee comprehensive health care by treating pathologies and acting from prevention. It offers a wide range of product categories, including prescription drugs, over-the-counter medications, naturals, mobility, and personal care. Out of which, the market-focused category is over-the-counter medications. The company is taking strategic initiatives to increase its product portfolio.

The company has a global presence in Central America, Asia-Pacific, Europe and Middle East. The company also has various subsidiaries such as Natural Distribution (Holdings) Ltd (UK), Natural Sante Limited(UK), Sakura Italia Srl (Italy), ORLIMAN, S.L.(Spain), Prodigo Inversiones 2010 SL (Spain), among others.